Eurofins Cerep SAS (ALECR) | Stock Overview & Key Data

Eurofins Cerep SAS | Small-cap | Healthcare

€17,600.00

0.00%

Eurofins Cerep SAS vs bioMérieux S.A Eurofins Cerep SAS vs Eurofins Scientific Eurofins Cerep SAS vs Klea Holding Eurofins Cerep SAS vs Predilife S.A Eurofins Cerep SAS vs Lumibird S.A Eurofins Cerep SAS vs CAC 40 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Eurofins Cerep SAS Performance Comparison

Loading chart data...

Performance Summary

Interactive charts require JavaScript. Here's the essential performance data:

Period	Eurofins Cerep SAS	Healthcare Sector	CAC 40
1 Week	-3.83%	N/A	N/A
1 Month	0.00%	N/A	N/A
3 Months	-14.56%	N/A	N/A
6 Months	-14.56%	N/A	N/A
1 Year	-10.66%	N/A	N/A
3 Years	-13.73%	N/A	N/A
5 Years	162.69%	N/A	N/A

Stock Range

Today's Range

Low: €17,600.00 High: €17,600.00

on August 7, 2025

52 Week Range

Low: €15,800.00 High: €21,800.00

on July 18, 2025

on October 11, 2024

All-Time High: €29,200.00 on July 17, 2023

Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights

Key Statistics

Market Cap i €88.8M

EPS i 1,418.56

P/E Ratio (TTM) i 12.41

Forward P/E i N/A

P/B Ratio i N/A

PEG Ratio i N/A

Div. Yield i N/A

ROE i 10.49%

Beta i 0.470

Debt to Equity i 0.46

Financial Highlights

Profitability

Gross Margin i N/A

Operating Margin i 13.38%

Profit Margin i 17.67%

Returns and Earnings

Return on Assets (TTM) i 3.22%

Return on Equity (TTM) i 10.49%

EBITDA i €8.6M

Net Income (TTM) i €7.2M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i €8,026.92

Quarterly Revenue Growth (YoY) i -8.60%

Quarterly Earnings Growth (YoY) i -2.20%

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Eurofins Cerep SAS ALECR	88.77M Small-cap	-3.83%	0.00%	-14.56%	-14.56%	-10.20%	-10.66%	-13.73%	162.69%
bioMérieux S.A BIM	14.53B Large-cap	0.48%	4.79%	7.78%	8.43%	21.42%	28.16%	22.08%	-9.64%
Eurofins Scientific ERF	11.98B Large-cap	0.82%	11.36%	18.42%	28.90%	36.27%	25.78%	-12.14%	1.43%
Klea Holding ALKLH	59.69M Small-cap	0.00%	5.56%	5.56%	0.00%	11.76%	11.76%	0.00%	0.00%
Predilife S.A ALPRE	12.80M Small-cap	-4.52%	-6.11%	-8.40%	-11.05%	-5.06%	-28.69%	-44.59%	-54.32%
Lumibird S.A LBIRD	441.19M Mid-cap	4.51%	8.84%	69.83%	159.21%	105.21%	98.59%	-10.05%	64.72%

Ownership & Short Interest

Insider Ownership i 95.78%

Institutional Ownership i 0.00%

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i N/A

Average 90-Day Volume i 2

Eurofins Cerep SAS Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Eurofins Cerep SAS would have performed over time.

Calculator Requires JavaScript

The investment calculator requires JavaScript to perform real-time calculations. Please enable JavaScript for the full experience.

Alternative: Manual Calculation

For historical performance data of Eurofins Cerep SAS, please visit the price history page to analyze returns manually.

Recent Performance Summary:

1 Week: -3.83%
1 Month: 0.00%
3 Months: -14.56%
1 Year: -10.66%

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is ALECR's 52-week high and low?

In the last 52 weeks, Eurofins Cerep SAS reached a high of €21,800.00 (on October 11, 2024) and a low of €15,800.00 (on July 18, 2025).

What is the market cap and P/E ratio for ALECR?

Curious about Eurofins Cerep SAS's size and valuation? Its market capitalization stands at 88.77M. When it comes to valuation, the P/E ratio (trailing twelve months) is 12.41, and the forward P/E (looking ahead) is N/A.

Does ALECR pay dividends? If so, what's the yield?

As for dividends, Eurofins Cerep SAS isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Eurofins Cerep SAS's main competitors or similar companies to consider before investing?

When looking at Eurofins Cerep SAS, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
bioMérieux S.A BIM	14.53B	Healthcare	Diagnostics & Research	28.16%	22.08%
Eurofins Scientific ERF	11.98B	Healthcare	Diagnostics & Research	25.78%	-12.14%
Klea Holding ALKLH	59.69M	Healthcare	Diagnostics & Research	11.76%	0.00%
Predilife S.A ALPRE	12.80M	Healthcare	Diagnostics & Research	-28.69%	-44.59%
Lumibird S.A LBIRD	441.19M	Healthcare	Diagnostics & Research	98.59%	-10.05%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Eurofins Cerep SAS? (e.g., ROE, Debt/Equity)

To get a sense of Eurofins Cerep SAS's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 10.49%, the Debt to Equity ratio from the most recent quarter is 0.46, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for ALECR?

Looking at Eurofins Cerep SAS's growth, its revenue over the trailing twelve months (TTM) was €40M. Compared to the same quarter last year (YoY), quarterly revenue grew by -8.60%, and quarterly earnings saw a YoY growth of -2.20%.

How much of ALECR stock is held by insiders and institutions?

Wondering who owns Eurofins Cerep SAS stock? Company insiders (like executives and directors) hold about 95.78% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.